Correlation Between Salesforce and Fulcrum Therapeutics

Can any of the company-specific risk be diversified away by investing in both Salesforce and Fulcrum Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Fulcrum Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Fulcrum Therapeutics, you can compare the effects of market volatilities on Salesforce and Fulcrum Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Fulcrum Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Fulcrum Therapeutics.

Diversification Opportunities for Salesforce and Fulcrum Therapeutics

0.79

Correlation Coefficient

Salesforce  Fulcrum Therapeutics

Poor diversification

The 3 months correlation between Salesforce and Fulcrum is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Fulcrum Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fulcrum Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Fulcrum Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fulcrum Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Fulcrum Therapeutics go up and down completely randomly.

Pair Corralation between Salesforce and Fulcrum Therapeutics

Considering the 90-day investment horizon Salesforce is expected to generate 0.5 times more return on investment than Fulcrum Therapeutics. However, Salesforce is 1.99 times less risky than Fulcrum Therapeutics. It trades about -0.18 of its potential returns per unit of risk. Fulcrum Therapeutics is currently generating about -0.16 per unit of risk. If you would invest  34,290  in Salesforce on December 23, 2024 and sell it today you would lose (6,228) from holding Salesforce or give up 18.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Salesforce  vs.  Fulcrum Therapeutics

Salesforce

Risk-Adjusted Performance

Very Weak

Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Fulcrum Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fulcrum Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Salesforce and Fulcrum Therapeutics

The main advantage of trading using opposite Salesforce and Fulcrum Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Fulcrum Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulcrum Therapeutics will offset losses from the drop in Fulcrum Therapeutics' long position.

The idea behind Salesforce and Fulcrum Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.